col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

65 Results       Page 1

The American Association of Immunologists: The Journal of Immunology
  original article Date Title Authors   All Authors
1 [GO] 2022―Apr―29 Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil Hyon-Xhi Tan, Kathleen M. Wragg, Hannah G. Kelly, Robyn Esterbauer, Benjamin J. Dixon, Jillian S. Y. Lau, et al. (+7)
2 [GO] 2022―Apr―04 Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients Xiaoming Yang, Alex C. Rutkovsky, Juhua Zhou, Yin Zhong, Julian Reese, Timothy Schnell, et al. (+4)
3 [GO] 2022―Apr―04 Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women Nardhy Gomez-Lopez, Roberto Romero, Li Tao, Meyer Gershater, Yaozhu Leng, Chengrui Zou, et al. (+13)
4 [GO] 2022―Apr―01 Virus-Specific Regulatory T Cells Persist as Memory in a Neurotropic Coronavirus Infection Alan Sariol, Jingxian Zhao, Juan E. Abrahante, Stanley Perlman
5 [GO] 2022―Mar―23 SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients Bo Zhai, Karen Clarke, David L. Bauer, Krissy K. Moehling Geffel, Saran Kupul, Lucas J. Schratz, et al. (+5)
6 [GO] 2022―Mar―14 Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients Yevgeniy Yuzefpolskiy, Peter Morawski, Mitch Fahning, Cate Speake, Sandra Lord, Anu Chaudhary, et al. (+7)
7 [GO] 2022―Feb―28 Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG Veronica P. Costantini, Kenny Nguyen, Zoe Lyski, Shannon Novosad, Ana C. Bardossy, Amanda K. Lyons, et al. (+9)
8 [GO] 2022―Feb―04 Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly Lil Meyer-Arndt, Tatjana Schwarz, Lucie Loyal, Larissa Henze, Beate Kruse, Manuela Dingeldey, et al. (+12)
9 [GO] 2022―Jan―31 Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine Alexey A. Komissarov, Inna V. Dolzhikova, Grigory A. Efimov, Denis Y. Logunov, Olga Mityaeva, Ivan A. Molodtsov, et al. (+6)
10 [GO] 2022―Jan―17 The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population Michael K. Tu, Samantha H. Chiang, Richard A. Bender, David T. W. Wong, Charles M. Strom
11 [GO] 2022―Jan―07 SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy Chao Sui, Tongyang Xiao, Shengyuan Zhang, Hongxiang Zeng, Yi Zheng, Bingyu Liu, et al. (+3)
12 [GO] 2022―Jan―05 Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease Taru S. Dutt, Stephanie M. LaVergne, Tracy L. Webb, Bridget A. Baxter, Sophia Stromberg, Kim McFann, et al. (+8)
13 [GO] 2021―Dec―13 Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset Jaclyn C. Law, Melanie Girard, Gary Y. C. Chao, Lesley A. Ward, Baweleta Isho, Bhavisha Rathod, et al. (+10)
14 [GO] 2021―Nov―24 ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling Beibei Wu, Arunachalam Ramaiah, Gustavo Garcia, Spyridon Hasiakos, Vaithilingaraja Arumugaswami, Sonal Srikanth
15 [GO] 2021―Oct―13 Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Kalipada Pahan
16 [GO] 2021―Oct―04 Cutting Edge: Lung-Resident T Cells Elicited by SARS-CoV-2 Do Not Mediate Protection Against Secondary Infection Lydia M. Roberts, Forrest Jessop, Tara D. Wehrly, Catharine M. Bosio
17 [GO] 2021―Oct―04 SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals Yanling Liu, Patrick Budylowski, Shilan Dong, Zhijie Li, Sofiya Goroshko, Leslie Y. T. Leung, et al. (+8)
18 [GO] 2021―Aug―27 Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19 Qianting Yang, Yanling Wen, Furong Qi, Xiang Gao, Weixin Chen, Gang Xu, et al. (+8)
19 [GO] 2021―Aug―20 SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis Inês Alves, Manuel Machado Vicente, Joana Gaifem, Ângela Fernandes, Ana Mendes Dias, Cláudia Sousa Rodrigues, et al. (+6)
20 [GO] 2021―Aug―13 Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence Tongcui Ma, Heeju Ryu, Matthew McGregor, Benjamin Babcock, Jason Neidleman, Guorui Xie, et al. (+8)
21 [GO] 2021―Aug―04 Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19 Daniel Reynolds, Cristina Vazquez Guillamet, Aaron Day, Nicholas Borcherding, Rodrigo Vazquez Guillamet, José Alberto Choreño-Parra, et al. (+6)
22 [GO] 2021―Jul―26 The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated Shima Shahbaz, Lai Xu, Wendy Sligl, Mohammed Osman, Najmeh Bozorgmehr, Siavash Mashhouri, et al. (+4)
23 [GO] 2021―Jul―23 SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain Rafael Bayarri-Olmos, Manja Idorn, Anne Rosbjerg, Laura Pérez-Alós, Cecilie Bo Hansen, Laust Bruun Johnsen, et al. (+10)
24 [GO] 2021―Jun―30 Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity William E. Matchett, Vineet Joag, J. Michael Stolley, Frances K. Shepherd, Clare F. Quarnstrom, Clayton K. Mickelson, et al. (+14)
25 [GO] 2021―Jun―28 SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19 José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós, Charbel Maroun-Eid, Verónica Terrón-Arcos, Karla Montalbán-Hernández, et al. (+14)
26 [GO] 2021―Jun―28 A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs Deli Huang, Jenny Tuyet Tran, Linghang Peng, Linlin Yang, Raymond T. Suhandynata, Melissa A. Hoffman, et al. (+13)
27 [GO] 2021―Jun―02 Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation Gautam Anand, Alexandra M. Perry, Celeste L. Cummings, Emma Raymond, Regina A. Clemens, Ashley L. Steed
28 [GO] 2021―May―28 Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19 Kenneth B. Hoehn, Palaniappan Ramanathan, Avraham Unterman, Tomokazu S. Sumida, Hiromitsu Asashima, David A. Hafler, et al. (+5)
29 [GO] 2021―May―28 Metabolic Defects of Peripheral T Cells in COVID-19 Patients Xiaoju Liu, Juanjuan Zhao, Haiyan Wang, Wan Wang, Xu Su, Xuejiao Liao, et al. (+3)
30 [GO] 2021―May―21 Influenza Virus and SARS-CoV-2 Vaccines Adam M. Sandor, Michael S. Sturdivant, Jenny P. Y. Ting
31 [GO] 2021―May―12 Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors Bernd Jahrsdörfer, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Carolin Ludwig, Tatjana Schwarz, et al. (+9)
32 [GO] 2021―May―12 Identification of T Cell Epitopes in the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 in Rhesus Macaques Xiaojuan Liu, Yuzhong Li, Hongjian Xiao, Yanwei Bi, Yue Gong, Zhengrong R. Hu, et al. (+6)
33 [GO] 2021―May―10 Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein Jake C. Harbour, Zoe L. Lyski, John B. Schell, Archana Thomas, William B. Messer, Mark K. Slifka, Jeffrey C. Nolz
34 [GO] 2021―May―10 Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination Bennett J. Davenport, Thomas E. Morrison, Ross M. Kedl, Jared Klarquist
35 [GO] 2021―May―05 Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain Grace Mantus, Lindsay E. Nyhoff, Robert C. Kauffman, Venkata Viswanadh Edara, Lilin Lai, Katharine Floyd, et al. (+11)
36 [GO] 2021―May―03 Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients Hidetsugu Fujigaki, Masato Inaba, Michiko Osawa, Saya Moriyama, Yoshimasa Takahashi, Tadaki Suzuki, et al. (+7)
37 [GO] 2021―Apr―28 Genome-Wide B Cell, CD4+, and CD8+ T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines Swayam Prakash, Ruchi Srivastava, Pierre-Gregoire Coulon, Nisha R. Dhanushkodi, Aziz A. Chentoufi, Delia F. Tifrea, et al. (+9)
38 [GO] 2021―Apr―12 Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients Qihong Yan, Pingchao Li, Xianmiao Ye, Xiaohan Huang, Bo Feng, Tianxing Ji, et al. (+12)
39 [GO] 2021―Mar―29 Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease Philip S. Crooke, John T. Tossberg, Krislyn P. Porter, Thomas M. Aune
40 [GO] 2021―Feb―12 The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression Wei Huang, Mei Li, Guangwei Luo, Xiaojie Wu, Bintao Su, Lan Zhao, et al. (+6)
41 [GO] 2021―Feb―08 T Cell Phenotyping in Individuals Hospitalized with COVID-19 Janine Rupp, Barbara Dreo, Katharina Gütl, Johannes Fessler, Adrian Moser, Bernd Haditsch, et al. (+5)
42 [GO] 2021―Feb―05 IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study Marco Franzetti, Andrea Forastieri, Noemi Borsa, Alessandro Pandolfo, Chiara Molteni, Luca Borghesi, et al. (+15)
43 [GO] 2021―Jan―13 Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses Vineet Joag, Sathi Wijeyesinghe, J. Michael Stolley, Clare F. Quarnstrom, Thamotharampillai Dileepan, Andrew G. Soerens, et al. (+20)
44 [GO] 2020―Dec―30 Coronavirus Receptors as Immune Modulators Charan Kumar V. Devarakonda, Emily Meredith, Mallika Ghosh, Linda H. Shapiro
45 [GO] 2020―Dec―09 Repurposed Tocilizumab in Patients with Severe COVID-19 Jianbo Tian, Ming Zhang, Meng Jin, Fengqin Zhang, Qian Chu, Xiaoyang Wang, et al. (+12)
46 [GO] 2020―Dec―09 A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients Henning Zelba, David Worbs, Johannes Harter, Natalia Pieper, Christina Kyzirakos-Feger, Simone Kayser, et al. (+4)
47 [GO] 2020―Dec―04 Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators Benjamin Schwarz, Lokesh Sharma, Lydia Roberts, Xiaohua Peng, Santos Bermejo, Ian Leighton, et al. (+6)
48 [GO] 2020―Nov―18 SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals Cecilie Bo Hansen, Ida Jarlhelt, Laura Pérez-Alós, Lone Hummelshøj Landsy, Mette Loftager, Anne Rosbjerg, et al. (+9)
49 [GO] 2020―Nov―18 Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile Jaclyn C. Law, Wan Hon Koh, Patrick Budylowski, Jonah Lin, FengYun Yue, Kento T. Abe, et al. (+10)
50 [GO] 2020―Nov―05 SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals Pedro Martínez-Fleta, Arantzazu Alfranca, Isidoro González-Álvaro, Jose M. Casasnovas, Daniel Fernández-Soto, Gloria Esteso, et al. (+11)
51 [GO] 2020―Oct―30 Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19 Erik H. Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen, Simone Kruithof, Pleuni Ooijevaar-de Heer, Gerard van Mierlo, et al. (+21)
52 [GO] 2020―Sep―25 Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19 Merve Kalkan Yazıcı, Meliha Meric Koç, Nesibe Selma Çetin, Elif Karaaslan, Gulay Okay, Bulent Durdu, et al. (+2)
53 [GO] 2020―Sep―21 Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm Alexandre E. Nowill, Pedro O. de Campos-Lima
54 [GO] 2020―Sep―04 Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns Nicole Baumgarth, Janko Nikolich-Žugich, F. Eun-Hyung Lee, Deepta Bhattacharya
55 [GO] 2020―Sep―02 Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients Renata Varnaitė, Marina García, Hedvig Glans, Kimia T. Maleki, John Tyler Sandberg, Janne Tynell, et al. (+10)
56 [GO] 2020―Aug―21 Neonatal and Children’s Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy Shokrollah Elahi
57 [GO] 2020―Aug―03 Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε Lok-Yin Roy Wong, Zi-Wei Ye, Pak-Yin Lui, Xuyang Zheng, Shuofeng Yuan, Lin Zhu, et al. (+9)
58 [GO] 2020―Jul―22 COVID-19: Complement, Coagulation, and Collateral Damage Martin W. Lo, Claudia Kemper, Trent M. Woodruff
59 [GO] 2020―Jul―17 SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production Rafael Franco, Rafael Rivas-Santisteban, Joan Serrano-Marín, Ana I. Rodríguez-Pérez, José L. Labandeira-García, Gemma Navarro
60 [GO] 2020―Jul―10 A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections Marika Orlov, Pandora L. Wander, Eric D. Morrell, Carmen Mikacenic, Mark M. Wurfel
61 [GO] 2020―Jun―26 A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection Wafaa B. Alsoussi, Jackson S. Turner, James B. Case, Haiyan Zhao, Aaron J. Schmitz, Julian Q. Zhou, et al. (+16)
62 [GO] 2020―Jun―08 Early Insights into Immune Responses during COVID-19 Ashley L. St. John, Abhay P. S. Rathore
63 [GO] 2020―Jun―03 Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19 Judy Chen, William J. Kelley, Daniel R. Goldstein
64 [GO] 2020―Jun―03 Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19 Jeremy K. Y. Yap, Miyu Moriyama, Akiko Iwasaki
65 [GO] 2020―May―18 COVID-19 as an Acute Inflammatory Disease Rose H. Manjili, Melika Zarei, Mehran Habibi, Masoud H. Manjili

65 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.019 sec